Home Early Presentation of Familial Paraganglioma with SDHB Mutation in a 13 year old Child and its Mother
Article
Licensed
Unlicensed Requires Authentication

Early Presentation of Familial Paraganglioma with SDHB Mutation in a 13 year old Child and its Mother

  • Angela H. Santiago , Brendan T. Campbell and D. Elizabeth Estrada
Published/Copyright: September 17, 2010
Journal of Pediatric Endocrinology and Metabolism
From the journal Volume 23 Issue 4

ABSTRACT

Paragangliomas are extradadrenal neuroendocrine tumors, recently associated with gene mutations in the succinate dehydrogenase complex (SDH). These mutations are thought to be responsible for the familial paraganglioma syndrome. Average age of tumor diagnosis for SDH mutation carriers is about 30 years of age, but patients younger than 10 years have been reported. We present the case of a 13 year-old boy with abdominal paraganglioma, whose mother also had a history of thoracic paraganglioma diagnosed at 14 years of age. Both were found to carry a mutation in exon 4 of the SDHB gene, heterozygous for c.418G>T, p.Val140Phe sequence. Compared to the other SDH subtypes, SDHB associated tumors have been found to be much more aggressive. This has led to current recommendations that tumor screening of asymptomatic SDHB carriers should start as early as 10 years of age. An even earlier initiation seems warranted for the identified carriers in this family.


Corresponding author: Angela Santiago, MD.

Published Online: 2010-09-17
Published in Print: 2010-April

© Freund Publishing House Ltd.

Articles in the same Issue

  1. Growth hormone (GH) testing nutrition and metabolic balance, do we have the full picture?
  2. Primary Aldosteronism and its Impact on the Generation of Arterial Hypertension, Endothelial Injury and Oxidative Stress
  3. Metaphyseal Condrodysplasia, Schmid-type, a Differential Diagnosis with Rickets
  4. Adiposity, Physical Activity and Blood Lipid Profile in 13-year-old Adolescents
  5. Relationship between Metabolic Parameters and Thyroid Hormones and the Level of Gastric Peptides in Children with Autoimmune Thyroid Diseases
  6. Stimulated Growth Hormone Concentrations in Obese Pediatric Patients with Mild and Severe Insulin Resistance: A Pilot Study
  7. Amiodarone-induced Thyrotoxicosis in Children and Adolescents is a Possible Outcome in Patients with Low Iodine Intake
  8. Analysis of Serum Adiponectin, Resistin and Leptin Levels in Children and Adolescents with Autoimmune Thyroid Disorders
  9. Molecular Diagnosis of 46,XY DSD and Identification of a Novel 8 Nucleotide Deletion in Exon 1 of the SRD5A2 Gene
  10. Can Auxology, IGF-I and IGFBP-3 Measurements Followed by MRI and Genetic Tests Replace GH Stimulation Tests in the Diagnosis of GH Deficiency in Children?
  11. Body Fat Measurements in Elite Adolescent Volleyball Players: Correlation between Skinfold Thickness, Bioelectrical Impedance Analysis, Air-displacement Plethysmography, and Body Mass Index Percentiles
  12. Autonomic Bladder Dysfunction in an Adolescent with Type 1 Diabetes
  13. Autoimune Thyroiditis and Diabetes Mellitus Type 1 after Long-term Gonadotropin-releasing Hormone Agonist Treatment for Central Precocious Puberty: Evolution or Coincidence?
  14. Novel Growth Hormone Receptor Gene Mutation in a Patient with Laron Syndrome
  15. A Novel Missense Mutation in the AVPR2 Gene of a Japanese Infant with Nephrogenic Diabetes Insipidus
  16. Early Presentation of Familial Paraganglioma with SDHB Mutation in a 13 year old Child and its Mother
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.066/html
Scroll to top button